NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/22/2024
Back to search
Official data from USPTO
CELIAC DISEASE FOUNDATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/22/2024
Classification
Registered
Trademark type
Combined
Nice classes
35, 42, 44
Filing date
08/30/2016
Registration date
10/10/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2024
Last transaction
03/22/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2013-09-00
First use in commerce
2013-09-00
Drawing code
3
Owner type
99
Owner location
Woodland Hills, CA, US
Examiner
LE, KHANH
Law office
M70
Current location
TMO LAW OFFICE 116
Mark description
The mark consists of the stylized words "CELIAC DISEASE" over the stylized word "FOUNDATION" with a stylized drawing of a butterfly to the left of the words.
Holders and representatives
Holders
C. F. (pessoa física)
Representatives
Peter G. Byrne, Esq. MORGAN, LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Public advocacy to promote awareness of celiac disease
Class 42
Providing a website featuring information in the field of celiac disease research
Class 44
Providing healthcare information; Providing a website featuring information in the field of preventiondetectiondiagnosis and treatment of celiac disease; Providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can communicate information about their medical experiences for support and community; Maintaining medical information of patients with celiac disease and gluten sensitivity
Publications
History of USPTO decisions and trademark events.
27 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/22/2024
E815
TEAS SECTION 8 & 15 RECEIVED
09/28/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2017
PUBO
PUBLISHED FOR OPPOSITION
07/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/21/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
06/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/19/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2017
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
12/10/2016
ALIE
ASSIGNED TO LIE
12/09/2016
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
12/09/2016
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
12/09/2016
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
12/09/2016
DOCK
ASSIGNED TO EXAMINER
12/08/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2016
NWAP
NEW APPLICATION ENTERED
09/02/2016
Continuous trademark protection
Get notified about every new filing that threatens CELIAC DISEASE FOUNDATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.